SCs migrate to the vicinity of the tumor and secrete CCL2 under signals derived from cervical cancer cells, which acts as a potent chemoattractant, inducing CCR2+ cervical cancer cells to undergo epithelial–mesenchymal transition (EMT) and move along neurites. The gene discussed is CCL2; the disease is cervical cancer.